Better Drugs: Patient Experience Matters More in Approval Process
This act ensures patient experiences are given more weight when evaluating new drugs. Pharmaceutical companies will need to submit patient data, and the Food and Drug Administration (FDA) must show how this information influenced drug approval decisions. This means citizens can expect drugs that better meet their needs and experiences.
Key points
Increased influence of patient experiences on new drug approvals.
Pharmaceutical companies must provide patient experience data.
FDA must explain how patient data influenced drug decisions.
Expired
Citizen Poll